The University Hospitals of Leicester (UHL) NHS Trust, with just under 2000 beds is one of the biggest and busiest trusts in the country, serving the one million residents of Leicester, Leicestershire and Rutland. Our nationally and internationally-renowned specialist treatment and services in cardio-respiratory diseases, ECMO, cancer and renal disorders reach a further two to three million patients from the rest of the country.
Leicester has an Experimental Cancer Medicine Centre and their HOPE Clinical Trials Facility is an instrumental factor in delivering clinical trials of new cancer treatments, which is generously supported by the locally-based charity Hope Against Cancer.
The heart centre at the Glenfield hospital continues to lead the way in developing new and innovative research and techniques, such as TAVI (Trans-Catheter Aortic Valve Insertion) and the use of the sutureless valves in heart surgery. It has also become one of the world’s busiest ECMO (extracorporeal membrane oxygenation) centres and the only hospital in the UK to provide ECMO therapy for both adults and children.
The University of Leicester is a leading university committed to international excellence, world-changing research and high quality, inspirational teaching. They are proud to be one of the world's leading research-intensive universities, elite in the excellence of their research.
The NIHR Leicester BRC is at the frontier of research into illnesses linked to respiratory conditions, cardiovascular disease, Type 2 diabetes, chronic kidney disease and the consequences of inactivity. Their overall purpose is to translate scientific breakthroughs in these areas into diagnostic tests, preventions and life-saving treatments for their patients.
UHL are one of the biggest and busiest NHS trusts in the country, serving the one million residents of Leicester, Leicestershire and Rutland - and increasingly specialist services over a much wider area. They are committed to research and development in order to improve patient care and at any one time there are more than 800 research projects active in the Trust.
The NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC) East Midlands, led by Professor Kamlesh Khunti, brings together a collaboration of local providers and commissioners of NHS services, universities, industry and other relevant organisations. It leads applied health research across the region, translating research findings into improved outcomes for patients.
The National Centre for Sport and Exercise Medicine (NCSEM) is an Olympic legacy project delivering education, research and clinical services in sport, exercise and physical activity. It aims to apply world-class expertise to policies and practice that will benefit the health and wellbeing of the nation – from everyday people at risk of ill health through to elite athletes.
The Clinical Research Facilities (CRF) mission is to support excellent early translational studies in order to increase understanding of disease, evaluate new treatments and improve the health of our patients.Leicester CRF provides the people, expertise, space and equipment to conduct world-class experimental medicine research and early phase clinical trials. Our facilities are integrated into clinical areas within specialities to provide a seamless link from the laboratory bench to bedside.
Leicester ECMC has expertise in developing novel therapeutic strategies to treat cancer, particularly lung cancer and haematological malignancies.
A cornerstone of the Centre’s research is to discover and develop novel phytochemicals as potential cancer chemopreventive agents and/or as potential adjuncts to chemotherapy. Biomarker studies aim to inform treatment decisions and monitor the effectiveness of therapies.
The Birmingham Paediatric ECMC is based at Birmingham Children’s Hospital, at the heart of the city at our Steelhouse Lane site. The unit provides specialist care for patients under the age of 16, with thriving teenagers and young adults (16-24) service managed in conjunction with University Hospitals Birmingham at the Queen Elizabeth Hospital.
The centre sees approximately 250 new cases per year across a wide geographical area, and frequently accepts referrals for early phase trial participation from centres nationwide. BCH is also the central hub for the Midlands Paediatric Oncology Shared Care Centres network which sees collaboration with smaller units across the Midlands.
The centre is currently in the process of facilities redevelopment, with the unit having outgrown its current home on ward 15 and oncology outpatients. In summer 2017 the £40 million, cancer and rare diseases centre is due to be completed; bringing world class facilities to what is already a world class care provider.
Over the past six years the NIHR Surgical Reconstruction and Microbiology Research centre (SRMRC) has developed a unique and cohesive multi-disciplinary environment for trauma research.
The centre is joint-funded by the National Institute for Health Research and the Ministry of Defence with match funding from University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham.
This is a place where basic scientists work alongside clinicians in areas including immunology, endocrinology, microbiology, neuroscience, biomedical engineering and computer engineering.